Iryna Horak Selected Research

dihydroberberine

8/2022

Berberine alkaloids inhibit the proliferation and metastasis of breast carcinoma cells involving Wnt/β-catenin signaling and EMT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iryna Horak Research Topics

Disease

2	Neoplasm Metastasis (Metastasis) 08/2022 - 10/2021
2	Lung Neoplasms (Lung Cancer) 10/2021 - 01/2019
2	Lewis Lung Carcinoma 10/2021 - 01/2019
2	Neoplasms (Cancer) 10/2021 - 01/2019
1	Breast Neoplasms (Breast Cancer) 08/2022

Drug/Important Bio-Agent (IBA)

2	AlkaloidsIBA 08/2022 - 10/2021
2	BerberineIBA 08/2022 - 10/2021
2	fullerene C60IBA 10/2021 - 01/2019
1	isoquinolineIBA 08/2022
1	dihydroberberineIBA 08/2022
1	epiberberineIBA 08/2022
1	berberrubineIBA 08/2022
1	FITC-annexin A5IBA 08/2022
1	Berberine AlkaloidsIBA 08/2022
1	Cadherins (E-Cadherin)IBA 08/2022
1	CateninsIBA 08/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Cytotoxins (Cytolysins)IBA 01/2019

Therapy/Procedure

1	Therapeutics 10/2021